Cybersecurity Management in Pharmaceutical and Biotechnology Industries — one page

DescriptionPharmaceutical and biotechnology companies offer an attractive target for cyberattacks because of their substantial investment in research and development, valuable intellectual property, connected IT and operational networks, and sensitive stores of data. According to the Cisco 2014 Annual Security Report, the Pharmaceutical Sector was a much greater target than other sectors. In fact, the amount of malware targeting Pharmaceuticals was just over 600% of the median across all industries. Consequences of a cyberattack can include stolen IP, repeated clinical trials, litigation, a frightening amount of lost revenue, and most importantly, damage to a company’s reputation. Victims of theft not only face massive internal issues but also find themselves targeted by class action lawsuits and regulatory actions.
PDF Versioncybersecurity-management-in-pharmaceutic.pdf (429.5 KiB)